Pemetrexed Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Pemetrexed (NDC 25021-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Pem04 0000 01)

Structural Formula (Pem04 0000 01)
FDA Label Image

Figure 1 (Pem04 0000 02)

Figure 1 (Pem04 0000 02)
FDA Label Image

Figure 2 (Pem04 0000 03)

Figure 2 (Pem04 0000 03)
FDA Label Image

Figure 3 (Pem04 0000 04)

Figure 3 (Pem04 0000 04)
This text provides data on survival probability and survival time in months for two groups of patients: PC and GC. The number of patients at risk at different time points is also shown.*
FDA Label Image

Figure 4 (Pem04 0000 05)

Figure 4 (Pem04 0000 05)
FDA Label Image

Figure 5 (Pem04 0000 06)

Figure 5 (Pem04 0000 06)
This text is about the survival probability of patients over time, comparing the treatment with Pemetrexed to a placebo. It includes the number of patients at risk at different time points in months. The data suggests that the treatment with Pemetrexed had more patients surviving at the observed time periods compared to those on the placebo.*
FDA Label Image

Figure 6 (Pem04 0000 07)

Figure 6 (Pem04 0000 07)
FDA Label Image

Figure 7 (Pem04 0000 08)

Figure 7 (Pem04 0000 08)
FDA Label Image

Figure 8 (Pem04 0000 09)

Figure 8 (Pem04 0000 09)
FDA Label Image

Figure 9 (Pem04 0000 10)

Figure 9 (Pem04 0000 10)
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pem04 0000 11)

Package Label – Principal Display Panel – Vial Label (Pem04 0000 11)
This text describes the contents of a single-dose vial intended for intravenous use only. It includes caution about it being a cytotoxic agent. The text also contains various codes, numbers, and references.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pem04 0000 12)

Package Label – Principal Display Panel – Vial Label (Pem04 0000 12)
This is a label information for a product containing disodium equivalent to 500 mg. The product is manufactured for SAGENT Pharmaceuticals in Schaumburg, IL, USA and made in China. The label includes a copyright notice for Sagent Pharmaceuticals and a unique identification number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.